TY - JOUR
T1 - Nevus Sebaceous Syndrome
AU - La Mendola, Flavia
AU - Catanzaro, Stefano
AU - Praticò, Andrea D.
AU - Polizzi, Agata
AU - Schepis, Carmelo
AU - Pirrone, Concetta
AU - Zanghì, Antonio
AU - Salafia, Stefania
AU - Ruggieri, Martino
AU - Lacarrubba, Francesco
AU - Micali, Giuseppe
AU - Verzì, Anna Elisa
AU - Sugarman, Jeffrey L.
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Nevus sebaceous (NS) is a hamartomatous disorder of the skin and adjacent tissues characterized by epidermal, follicular, sebaceous, and apocrine gland abnormalities. It occurs in approximately 1 in 1,000 live births. A hyperactivation of Ras pathways has been recently assumed to be the cause of this phenotype. NS lesions may be isolated or coupled with extracutaneous manifestations, mostly of the central nervous, ocular, and skeletal systems, or kidneys; in this case, the term NS syndrome is used. Cutaneous distribution of NS usually follows the linear patterns known as lines of Blaschko, with lines that do not follow the segmental trajectory of the peripheral sensory nerves but instead reflect the streams or trends of growth of embryonic tissues. Histological characteristics of the lesions appear to be actually more decisive than the clinical evaluation to distinguish between the types of epidermal nevus: the typical NS has both papillated epidermal hyperplasia and a predominance of subjacent abnormal follicular-sebaceous glands. Seizures, mental retardation, and/or cognitive developmental delay are the most common neurologic abnormalities associated with NS and usually are present within the first months of life; eye and skeletal involvement may be present as well. The definitive treatment of NS is full-thickness excision. However, the necessity and timing of excision to prevent possible future malignancy are not clear; lasers and photodynamic therapy are alternatives currently being explored for the treatment of NS, with varying degrees of success.
AB - Nevus sebaceous (NS) is a hamartomatous disorder of the skin and adjacent tissues characterized by epidermal, follicular, sebaceous, and apocrine gland abnormalities. It occurs in approximately 1 in 1,000 live births. A hyperactivation of Ras pathways has been recently assumed to be the cause of this phenotype. NS lesions may be isolated or coupled with extracutaneous manifestations, mostly of the central nervous, ocular, and skeletal systems, or kidneys; in this case, the term NS syndrome is used. Cutaneous distribution of NS usually follows the linear patterns known as lines of Blaschko, with lines that do not follow the segmental trajectory of the peripheral sensory nerves but instead reflect the streams or trends of growth of embryonic tissues. Histological characteristics of the lesions appear to be actually more decisive than the clinical evaluation to distinguish between the types of epidermal nevus: the typical NS has both papillated epidermal hyperplasia and a predominance of subjacent abnormal follicular-sebaceous glands. Seizures, mental retardation, and/or cognitive developmental delay are the most common neurologic abnormalities associated with NS and usually are present within the first months of life; eye and skeletal involvement may be present as well. The definitive treatment of NS is full-thickness excision. However, the necessity and timing of excision to prevent possible future malignancy are not clear; lasers and photodynamic therapy are alternatives currently being explored for the treatment of NS, with varying degrees of success.
KW - brain malformations
KW - epilepsy
KW - hamartoma
KW - nevus sebaceous
KW - ocular involvement
KW - Schimmelpenning's syndrome
UR - http://www.scopus.com/inward/record.url?scp=85054524645&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054524645&partnerID=8YFLogxK
U2 - 10.1055/s-0038-1667170
DO - 10.1055/s-0038-1667170
M3 - Review article
AN - SCOPUS:85054524645
SN - 1304-2580
VL - 16
SP - 338
EP - 346
JO - Journal of Pediatric Neuroradiology
JF - Journal of Pediatric Neuroradiology
IS - 5
ER -